Catalyst Wire Dossier Catalyst Wire Dossier

NaBen

· SyneuRx International (Taiwan) Corp
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NaBen, covering 2021-09-13 to 2024-05-24. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in Adults [Phase 2, Phase 3]

See pricing